Clinical Trial Highlight: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (Imvax 14379-201)
Full story About: Clinical Trial Highlight: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma (Imvax 14379-201)
Contact Us
University of CincinnatiCancer Center
231 Albert Sabin Way, Suite 2005
Cincinnati, OH 45267
Phone: 513-558-2177
Fax: 513-558-2666